Hormone Replacement Therapy Prescription after Premature Surgical Menopause
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This paper examined the prescribing patterns of hormone replacement therapy following surgical menopause in women who had their ovaries removed before the natural age of menopause.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Study objectiveTo assess hormone replacement therapy (HRT) prescription pattern in patients undergoing premature surgical menopause on the basis of surgical indication.DesignRetrospective cohort study.SettingAcademic tertiary care center.PatientsSurgically menopausal patients aged ≤45 years who underwent a minimally invasive hysterectomy with salpingo-oophorectomy.InterventionsHRT prescription in the 6-week postoperative period.Measurements and main resultsA total of 63 patients met inclusion criteria. Of these, 52% (n = 33) were prescribed HRT in the 6-week postoperative period. Indications for surgical menopause included pelvic pain or endometriosis (31.7%), gynecologic malignancy (20.6%), BRCA gene mutation (17.4%), breast cancer (9.5%), Lynch syndrome (4.8%), and other (15.8%). In total, 80% of patients with pelvic pain, 25% with gynecologic malignancies, 45% with BRCA gene mutations, 33.3% with breast cancer, and 66.6% with Lynch syndrome used HRT postoperatively. In patients who used HRT postoperatively, 76% were offered preoperative HRT counseling. This is in contrast with those patients who did not use HRT postoperatively, of whom only 33% were offered HRT counseling (p <.001). Perioperative complications were not predictive of HRT use postoperatively. In patients who did not use HRT postoperatively, 13.3% used alternative nonhormonal therapy.ConclusionIn patients who underwent premature surgical menopause, 52% used HRT postoperatively. Patients with pelvic pain and Lynch syndrome were more likely to use HRT, whereas those with gynecologic or breast malignancies and BRCA gene mutations were less likely to use HRT. Preoperative HRT counseling was associated with postoperative HRT use.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (30)
- Endometriosis Persisting After Castration via openalex
- Endometriosis persisting after castration: clinical characteristics and results of surgical management. via openalex
- Hormone replacement therapy in women with past history of endometriosis via openalex
- Practice Bulletin No. 114: Management of Endometriosis via openalex
- Recurrence in Deep Infiltrating Endometriosis: A Systematic Review of the Literature via openalex
- Timing of Estrogen Replacement Therapy Following Hysterectomy With Oophorectomy for Endometriosis via openalex
- W2036561561 via openalex
- W2070547371 via openalex
- W2106485489 via openalex
- W2106616822 via openalex
- W2125343928 via openalex
- W2137015189 via openalex
- W2146803019 via openalex
- W2148472826 via openalex
- W2149994587 via openalex
- W2159127722 via openalex
- W2161226706 via openalex
- W2515721699 via openalex
- W2538846010 via openalex
- W2559178581 via openalex
- W2564759100 via openalex
- W2765514025 via openalex
- W2890599160 via openalex
- W2909295258 via openalex
- W6662307027 via openalex
- W1725742191 via openalex
- W1979582754 via openalex
- W2003149618 via openalex
- W2019895899 via openalex
- W2033068288 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-07-31T06:09:14.520117+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:11.167363+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK